← Open Payments lookup

JOSEPHINE DEGUZMAN: Open Payments

NPI 1043391675 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$32,308 in 129 payments from 9 companies in 2025. Trend: 2023 $1,238 · 2024 $1,499 · 2025 $32,308

Speaker / faculty: $27,160Travel & lodging: $2,529Food & beverage: $2,159Consulting: $460
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.45$31,076
Alkermes, Inc.22$400
Neurocrine BioSciences, Inc.22$229
Lundbeck LLC10$192
Vanda Pharmaceuticals Inc.9$143
Janssen Pharmaceuticals, Inc13$136
E.R. Squibb & Sons, L.L.C.4$70
Otsuka America Pharmaceutical, Inc.2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31

Products named: UZEDY, AUSTEDO XR, ARISTADA, INGREZZA, ABILIFY ASIMTUFII, FANAPT, INVEGA SUSTENNA, COBENFY.

Industry payments across OK — which companies pay providers there.